12.60
0.00
(0.00%)
As of April 15 at 8:02:51 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 7 | 7 |
| Avg. Estimate | 774.79M | 797.26M | 3.19B | 3.32B |
| Low Estimate | 771.36M | 776.4M | 3.13B | 2.25B |
| High Estimate | 779.6M | 809M | 3.27B | 3.6B |
| Year Ago Sales | 798M | 829M | 3.55B | 3.19B |
| Sales Growth (year/est) | -2.91% | -3.83% | -10.04% | 3.88% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HQ7.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 3/10/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/27/2025 |
| Maintains | Guggenheim: Buy to Buy | 11/19/2024 |
| Maintains | JP Morgan: Underweight to Underweight | 11/12/2024 |
| Upgrade | Wells Fargo: Underweight to Equal-Weight | 11/7/2024 |
| Maintains | Wells Fargo: Underweight to Underweight | 3/1/2024 |